This bill revises New Jersey law governing advanced practice nurses (APNs) and is designed to expand APN autonomy in clinical practice. It removes or reduces several physician-collaboration requirements, most notably by allowing qualified APNs to practice without a joint protocol with a collaborating physician if they have more than 5,000 hours of licensed, active advanced nursing practice in an applicable population focus and are providing primary health care or behavioral health care, subject to specified exclusions. The bill also updates definitions in the nursing statutes and clarifies that APNs may perform a broader range of functions, including diagnosing, ordering tests, prescribing medications and devices, authorizing medical cannabis, and in some cases dispensing narcotic drugs for maintenance or detoxification treatment.
The bill also creates a transition rule for APNs who were already practicing without a joint protocol under Executive Order No. 13 (2026), allowing them to continue under certain conditions while they meet the new hour threshold. It directs the Board of Nursing and the Commissioner of Health to adopt implementing regulations immediately, including procedures for verifying practice hours, and states that those rules may not be more restrictive than the underlying statute. In addition, the bill amends related provisions so that where state law requires a physician signature, stamp, verification, affidavit, or endorsement, an APN may satisfy that requirement to the extent consistent with APN scope of practice.
The bill’s impact on state law is significant because it changes the long-standing collaborative-practice framework for APNs in New Jersey. It amends multiple sections of the nursing statutes, the controlled dangerous substances/joint protocol provisions, and the medical cannabis and substance use disorder treatment provisions to align with the new independent-practice model. It also preserves Board of Nursing authority over licensure, discipline, continuing education, and scope-of-practice enforcement, while limiting the ability of regulations to impose more restrictive requirements than the statute itself.
Overall sentiment appears favorable toward expanding APN practice authority, as reflected in the committee vote to report the substitute by an 11-2 margin. The bill’s findings emphasize access to care, physician shortages, and the lack of reported adverse incidents during prior waiver periods, suggesting strong support for the measure as a workforce and access-to-care response. The absence of recorded committee testimony in the provided materials limits the detail available on debate, but the vote indicates substantial support in committee.
The main point of contention is the removal of physician collaboration and joint protocol requirements, especially for prescribing and ordering medications, including controlled substances and medical cannabis. Supporters appear to view these restrictions as barriers to access, particularly in underserved areas and behavioral health settings, while opponents likely worry about patient safety, oversight, and the adequacy of APN training and experience. The bill addresses some of those concerns by imposing a 5,000-hour experience threshold, continuing education requirements, malpractice coverage, and reporting obligations for independently practicing APNs.
The bill amends the New Jersey nursing statutes and related controlled-substance and medical-cannabis provisions to expand the authority of advanced practice nurses and reduce mandatory physician collaboration in certain settings. It creates a statutory pathway for qualified APNs to practice independently, prescribes conditions for independent prescribing and authorization authority, and requires immediate regulatory implementation by the Board of Nursing and the Commissioner of Health. It also broadens the legal recognition of APN signatures and certifications in place of physician sign-offs where consistent with APN scope.
The general sentiment appears supportive of the bill’s goal of expanding access to care through greater APN autonomy. The Assembly Appropriations Committee reported the substitute favorably by an 11-2 vote, indicating meaningful but not unanimous support. The bill’s findings and structure reflect a policy preference for easing practice restrictions, especially in light of workforce shortages and prior emergency waivers that reportedly did not produce adverse incidents.
The central controversy is whether APNs should be allowed to practice, prescribe, and authorize treatment without a collaborating physician or joint protocol. Supporters emphasize access, rural and underserved care, and the success of prior waiver periods; opponents are likely concerned about oversight, controlled-substance prescribing, and whether independent practice should be limited to highly experienced APNs. Additional tension may arise over the bill’s broad substitution of APN authority for physician signatures and its immediate implementation requirements.